P2RX7 and limb-girdle muscular dystrophy: In light of these considerations, strategies aimed at reducing muscle inflammation, increasing the amount of Treg infiltrating an injured muscle and exerting a systemic anti-inflammatory effect, i.e., antagonists of P2X7, might represent a therapeutic approach for LGMD R3.